Also notes the critical role of science, technology and innovation in building resilience to, combating and recovering from the COVID-19 pandemic, including in the development of safe and effective COVID-19 vaccines at remarkable speed using breakthrough technologies, and in this regard recognizes the importance of initiatives such as the COVID-19 Vaccine Global Access (COVAX) Facility, the vaccines pillar of the Access to COVID-19 Tools Accelerator supported by the World Health Organization and global partners, and other relevant initiatives aimed at speeding up the search for safe and effective tests, treatments and vaccines for all countries, while remaining concerned, however, at the continued need to expand equitable access to diagnostics, treatments, vaccines and other health technologies for the COVID-19 pandemic, and in this regard calls upon Member States, the United Nations, the private sector and other relevant stakeholders to continue to initiate, implement and support effective measures to strengthen international cooperation and action towards strengthening health systems, universal health coverage and health infrastructures and promote increased access to affordable, safe, effective and quality medicines, including generics, vaccines, diagnostics and health technologies, reaffirming the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) as amended, and also reaffirming the 2001 World Trade Organization Doha Declaration on the TRIPS Agreement and Public Health, which recognizes that intellectual property rights should be interpreted and implemented in a manner supportive of the right of Member States to protect public health and, in particular, to promote access to medicines for all, and notes the need for appropriate incentives in the development of new health products;
